Certain SNPs in the FGFR2 gene have been found to be associated with BC risk [4, 10] and with the transcription factors Oct1 and Runx2, which can cluster with the estrogen receptor (ER) binding site. This evidence concerns the gene FGFR2 and breast cancer.